Evidence map›Paper›PMID 34541388›Full record

ReviewBioactive materials2022

How far is Lignin from being a biomedical material?

Sigit Sugiarto, Yihao Leow, Chong Li Tan, Guan Wang, Dan Kai

Open access · goldAbstract readReview
In one paragraph

Review in Bioactive materials, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
15.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 242 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Sigit SugiartoInstitute of Materials Research and Engineering (IMRE), ASTAR, 2 Fusionopolis Way, Innovis, #08-03, Singapore 138634 Singapore.
Yihao LeowInstitute of Materials Research and Engineering (IMRE), ASTAR, 2 Fusionopolis Way, Innovis, #08-03, Singapore 138634 Singapore.
Chong Li TanInstitute of Materials Research and Engineering (IMRE), ASTAR, 2 Fusionopolis Way, Innovis, #08-03, Singapore 138634 Singapore.
Guan WangInstitute of Materials Research and Engineering (IMRE), ASTAR, 2 Fusionopolis Way, Innovis, #08-03, Singapore 138634 Singapore.
Dan KaiInstitute of Materials Research and Engineering (IMRE), ASTAR, 2 Fusionopolis Way, Innovis, #08-03, Singapore 138634 Singapore.
Agency for Science, Technology and Research · SG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lignin is a versatile biomass that possesses many different desirable properties such as antioxidant, antibacterial, anti-UV, and good biocompatibility. Natural lignin can be processed through several chemical processes. The processed lignin can be modified into functionalized lignin through chemical modifications to develop and enhance biomaterials. Thus, lignin is one of the prime candidate for various biomaterial applications such as drug and gene delivery, biosensors, bioimaging, 3D printing, tissue engineering, and dietary supplement additive. This review presents the potential of developing and utilizing lignin in the outlook of new and sustainable biomaterials. Thereafter, we also discuss on the challenges and outlook of utilizing lignin as a biomaterial.

Indexed as

3D printingAntioxidantsBiomassBiomedical applicationsTissue engineering

Identifiers

PMID34541388
PMCPMC8424518
OpenAlexW3177263514

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.